Skip to main content

Table 2 Period means and ranges for pre- and 10 min post-allergen challenge mean TNSS and mean nasal PIF over the last three days of the allergen challenge series.

From: Effects of a dual CCR3 and H1-antagonist on symptoms and eosinophilic inflammation in allergic rhinitis

    Pre challenge 10 min post challenge
Variable Treatment n Mean Range Mean Range
TNSS AZD3778 35 1.25 0, 3 4.11 0.7, 7.7
  Loratadine 35 1.64 0, 8 3.85 1, 8
  Placebo 34 1.56 0, 5.5 5.57 1.7, 9
Nasal
PIF
AZD3778 35 179 76.7, 247 125 50, 200
  Loratadine 35 165 50, 243 114 30, 210
  Placebo 34 177 100, 257 108 57, 177